LOGIN 

 

JOIN

 

RENEW

2021 Press Releases

HomeAboutNewsroomPress ReleasesPress Releases from the ATS2021 Press Releases ▶ Claims E-cigarettes Are a Harm Reduction Tool Unproven; American Thoracic Society Reacts to FDA Decision
Claims E-cigarettes Are a Harm Reduction Tool Unproven; American Thoracic Society Reacts to FDA Decision

Oct. 13, 2021 – “The ATS reiterates our long-held position – e-cigarettes are not ‘safe’ and the claims that e-cigarettes are a harm reduction tool remain unproven.  All e-cigarettes have significant health risks including nicotine addiction and respiratory disease,” said ATS President Lynn Schnapp, MD, ATSF.  

The ATS notes that the FDA has finally issued decisions on e-cigarette products that constitute a large share of the e-cigarette market. This is an important step by the FDA to finally reign in the U.S. e-cigarette marketplace. 

We are concerned that the agency has approved Vuse products with high nicotine concentration.  While we appreciate that the FDA rejected RJR/Vuse application for flavored e-cigarette products, we note with concern that the agency has not yet rejected the Vuse application for menthol e-cigarette products.  The presence of any flavored e-cigarette product poses an unacceptable risk to our nation’s youth.  

The ATS calls on the FDA to protect our nation’s youth by rejecting all flavored e-cigarette products – including menthol flavored e-cigarettes.